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Objective: Glycosphingolipids (GSLs) are ubiquitous membrane components that play a functional role in
maintaining chondrocyte homeostasis. We investigated the potential role of gangliosides, one of the
major components of GSLs, in osteoarthritis (OA) pathogenesis.
Design: Both age-associated and instability-induced OA models were generated using GM3 synthase
knockout (GM3S/) mice. A cartilage degradation model and transiently GM3S-transfected chondrocytes
were analyzed to evaluate the function of gangliosides in OA development. The amount of each series of
GSLs in chondrocytes after IL-1a stimulation was proﬁled using mass spectrometry (MS).
Results: OA changes in GM3S/mice were dramatically enhanced with aging compared to those in wild-
type (WT) mice. GM3S/ mice showed more severe instability-induced pathologic OA in vivo. Gangli-
oside deﬁciency also led to the induction of matrix metalloproteinase (MMP)-13 and ADAMTS-5 secre-
tion and chondrocyte apoptosis in vitro. In contrast, transient GM3S transfection of chondrocytes
suppressed MMP-13 and ADAMTS-5 expression after interleukin (IL)-1a stimulation. GSL proﬁling
revealed the presence of abundant gangliosides in chondrocytes after IL-1a stimulation.
Conclusion: Gangliosides play a critical role in OA pathogenesis by regulating the expression of MMP-13
and ADAMTS-5 and chondrocyte apoptosis. Based on the obtained results, we propose that gangliosides
are potential target molecules for the development of novel OA treatments.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
The pathology of osteoarthritis (OA) is characterized by a pro-
gressive degradation of articular cartilage. In healthy individuals,
the homeostasis of articular cartilage is maintained primarily by
chondrocytes that are responsible for the synthesis and degrada-
tion of the extracellular matrix (ECM). However, the actual mech-
anism(s) of cartilage degradation remain unclear, despite a large
number of gene- and protein-based studies designed to address the
process1e3. The development of OA therapies will require the: T. Onodera, Department of
School of Medicine, Kita 15,
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s Research Society International. Pidentiﬁcation of newmolecular targets involved in the degradation
mechanism.
Glycosphingolipids (GSLs) are a group of glycolipids that are
widely distributed on vertebrate plasma membranes. These mole-
cules form clusters on cell membranes, where the GSLs modulate
transmembrane signaling and mediate cell-to-cell and cell-to-
matrix interactions4,5. GSLs are known to be critical for the main-
tenance of chondrocyte homeostasis6. However, mice that are ho-
mozygous null for Ugcg (the gene encoding UDP-glucose ceramide
glucosyltransferase (GlcCer synthase), the ﬁrst committed step in
GSL synthesis) also exhibit an embryonic lethal phenotype7,8.
Nonetheless, speciﬁc subclasses of GSLs that inﬂuence individual
systems and conditions are considered ideal targets for clinical
applications.
GSLs comprise diverse types of glycolipids, and are classiﬁed
into several groups depending on their structural features,
including lacto-series, neo lacto-series, globo-series, isoglobo-
series, and ganglio-series (gangliosides) [Fig. 1]9. Gangliosides
constitute one of themost abundantmolecules inmammalian cells.
In the context of OA, previous studies have shown that the total
ganglioside content of OA cartilage is decreased by 40%10,11.ublished by Elsevier Ltd. All rights reserved.
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Fig. 1. Schematic of the GSL synthetic pathway in mammalian cells. GSLs from cer-
amide through glucosylceramide (GlcCer) are synthesized by GlcCer synthase, encoded
by the Ugcg locus. Lactosylceramide (LacCer) is the key branching point of GSL
biosynthesis, with four alternate pathways (lacto-series, neo lacto-series, globo-series,
and isoglobo-series) branching off from LacCer. Virtually all the ganglio-series GSLs
(gangliosides) are detected as a-series and b-series gangliosides, both of which are
synthesized from the shared precursor molecule GM3, itself the product of GM3
synthase (GM3S, encoded by the GM3S locus). The o-series gangliosides typically are
detected only in trace amounts.
F. Sasazawa et al. / Osteoarthritis and Cartilage 22 (2014) 313e322314Additional research revealed that gangliosides suppress the secre-
tion of interleukin (IL)-17 and prevent the progression of collagen-
induced arthritis in mice12.
These results suggest that gangliosides may play a crucial role in
OA pathogenesis. To test this hypothesis, we employed a strain of
mice genetically engineered to lack GM3 synthase (GM3S). GM3
serves as a precursor molecule for most of the more complex
ganglioside species; mice lacking GM3S are deﬁcient in almost all
of the gangliosides synthesized from GM313. The aim of the present
study was to analyze the functional roles of gangliosides in OA
pathogenesis, thereby validating the GM3S as a potential clinical
target molecule in the treatment of OA.
Method
Animals and generation of gene deletions
GM3 synthase knockout (GM3S/) mice were generated as
described previously13. Male adult (4-week-old and 8-week-old)
and 6-day-old C57BL/6 mice were purchased from Japan SLC, Inc.
(Hamamatsu, Japan). Mice were utilized after 7-day-acclimatiza-
tion following transportation14. All the purchased mice recovered
normal behavior within 24 h after transportation. Mice were
housed in a temperature- and humidity-controlled environment
under 12-h light/12-h dark conditions and fed a standard rodent
diet. All experiments were performed according to a protocol
approved by the Institutional Animal Care and Use Committee of
the Hokkaido University Graduate School of Medicine (Sapporo,
Japan).
Age-associated OA model
As amodel of age-associated OA, joints were compared between
wild-type (WT; GM3Sþ/þ) and mutant (GM3S/) mice sacriﬁced
at 4 or 15 months of age. For each animal, the entire knee joint
was dissected and evaluated for the spontaneous development
of OA15,16.Instability-induced OA model
An instability-induced OA model was created in 8-week-old WT
or mutant mice as previously described15,17,18. Animals were anes-
thetized and the right knee joint was destabilized by transection of
the medial collateral ligament and removal of the cranial half of the
medial meniscus using a microsurgical technique (OA side). A sham
operation was performed on the left knee joint using the same
approach without ligament transection and meniscectomy (sham
side). Mice were recovered for 8 weeks and then sacriﬁced for
histologic assessment.
Histologic analysis
Samples were ﬁxed in 10% buffered formalin, decalciﬁed in 10%
ethylenediaminetetraacetate (pH 7.5), dehydrated, embedded in
parafﬁn, and sectioned at 5-mm thicknesses. Sections then were
subjected to staining with hematoxylin and eosin (H&E) and
Safranin O. OA severity in each mouse was quantiﬁed using the
Mankin scoring system19,20. In addition, we evaluated the changes
in synovium and subchondral bones using a scoring system with
low power images. We used the same scoring system previously
described12. Each sample was evaluated independently by three
observers who were blinded with regard to experimental group,
and the resulting scores were averaged to provide a mean score.
Culture of femoral head cartilage explant
In vitro cartilage catabolism was analyzed by culturing mouse
femoral head cartilage with IL-1a (Sigma, St. Louis, MO)15,21,22. The
femoral head cartilage was harvested from 4-week-old mice and
precultured for 48 h at 37C in a humidiﬁed atmosphere of 5% CO2
and 95% air, using Dulbecco’s modiﬁed Eagle’s medium (DMEM;
Sigma) containing 1% antibiotic solution (penicillinestreptomycin,
Gibco-BRL, Grand Island, NY), 2 mM glutamine (Wako, Osaka,
Japan), 10 mM 4-(2-HydroxyEthyl)-1-PiperazineEthaneSulfonic
acid (HEPES) (Gibco-BRL), 50 mg/ml ascorbate (Sigma), and 10% fetal
bovine serum (FBS; Nichirei Biosciences Inc., Tokyo, Japan). The
explants then were washed three times with serum-free DMEM
and cultured for an additional 72 h in serum-free DMEM containing
10 ng/ml mouse IL-1a.
Immunohistochemistry
Processed but unstained sections of mouse femoral head cartilage
were deparafﬁnized, and endogenous peroxidase activity was
quenched. After treatment with chondroitinase ABC (0.25 units/ml,
SigmaeAldrich, Tokyo, Japan), the sections were incubated overnight
at 4C with polyclonal antibody against the carboxyl-terminus of
matrix metalloproteinase (MMP)-13 (1:200 dilution; Chemicon,
Temecula, CA). Samples then were washed three times with
phosphate-buffered saline (PBS) and incubated with a biotinylated
secondary antibody, the primary antibody was omitted for the nega-
tive control. For semi-quantitative data, at 400 magniﬁcation, the
positive cells were counted from three different ﬁelds of observation;
the number of counted cellswas then averaged. Positive cell ratiowas
calculated with the total chondrocyte number of each ﬁeld. Each
sample was evaluated independently by three observers who were
blindedwith regard to the experimental groups theywere observing.
Terminal deoxynucleotidyl transferase dUTP nick-end labeling
(TUNEL) assay
To investigate chondrocyte apoptosis, the TUNEL assay was
performed using an in situ Apoptosis Detection Kit according to the
F. Sasazawa et al. / Osteoarthritis and Cartilage 22 (2014) 313e322 315recommendations of the manufacturer (Takara Bio Inc., Otsu,
Japan). For a negative control, terminal transferase in the TUNEL
reaction mixture was omitted. TUNEL-positive cell ratio was
calculated as described above.
Proteoglycan release from cultured mouse cartilage explants
To quantify the proteoglycan release from mouse cartilage ex-
plants with cartilage degradation, the proteoglycan content in the
medium and digested cartilage was measured as sulfated glycos-
aminoglycan using a dimethylmethylene blue assay as previously
described15,21. The amount of proteoglycan released from a mouse
cartilage explant into the medium was quantitatively expressed as
the percentage release of proteoglycan (proteoglycan amount in the
medium divided by the total amount of proteoglycan in the serum
and cartilage explants  100).
Enzyme-linked immunosorbent assay (ELISA)
MMP-13 in the mouse femoral head culture supernatant was
measured using an ELISA kit for mouse MMP-13 according to the
recommendations of the manufacturer (USCN Life Science, Hous-
ton, TX).
Quantiﬁcation of nitric oxide (NO)
NO in the mouse femoral head culture supernatant was quan-
tiﬁed based on the amount of nitrite, the product generated upon
degradation of NO23. A Griess reagent system was used for this
assay according to the recommendations of the manufacturer
(Promega, Tokyo, Japan).
Isolation of chondrocytes
Immature mouse chondrocytes were obtained from the hip and
knee joints of 6-day-old mice as previously described24,25. Isolated
primary mouse chondrocytes were cultured for 24 h in serum-free
DMEM plus 10 ng/ml mouse IL-1a for further analysis.
Quantitative real-time reverse transcriptase-polymerase chain
reaction (RT-PCR)
Total RNA was extracted from the samples using the RNeasy
Mini kit (Qiagen, Hilden, Germany). For complementary DNA syn-
thesis, 1.0 mg of RNA was reverse-transcribed using random hex-
amer primers (Promega) and ImProm II reverse transcriptase
(Promega). Real-time RT-PCR was performed using an Opticon II
system (Bio-Rad, Tokyo, Japan). Signals were detected using an
SYBR Green qPCR Kit (Finnzymes, Yokohama, Japan) with the gene-
speciﬁc primers (Supplementary Table I). The relative messenger
RNA (mRNA) expression of each targeted genewas expressed as the
Ct value of each gene normalized to the Ct value of the GAPDH-
encoding gene by using the DDCt method26.
Plasmid preparation and transient transfection
Plasmid vectors were designed by and purchased from Ori-
Gene (Rockville, MD). The expression vector for GM3S was St3gal5
(NM_001035228) Mouse cDNA Clone (OriGene MC209401) and
the mock control vector was pCMV6-Entry (OriGene PS100001).
Mouse chondrocytes were seeded in 24-well tissue culture plates
at 6  104 cells/well. After 24 h, the chondrocytes were trans-
fected using Lipofectamine LTX (Invitrogen, Carlsbad, CA). For
each well of a Lipofectamine LTX transfection, 500 ng DNA was
combined with 1.25 ml Plus Reagent (Invitrogen) in 100 ml Opti-MEM I reduced serum medium (Gibco/Invitrogen, Carlsbad, CA)
for 5 min. Lipofectamine LTX (5 ml) was added to the wells, and
the mixture was incubated for 30 min. An aliquot of 100 ml DNA/
Lipofectamine LTX complex was added to each well and mixed
gently. After 24 h incubation, the cells were rinsed twice with PBS
and placed in DMEM containing 1% antibiotic solution and 10%
FBS for 24 h27. Finally, cells were rinsed twice with PBS and
incubated in serum-free DMEM with or without 10 ng/ml IL-1a
for 12 h.
Quantiﬁcation of GSLs in the cultured mouse chondrocytes
GSLs were recovered from mouse chondrocyte pellets, cultured
with IL-1a for 0, 6, 12, 24, and 48 h, by chloroformemethanol
extraction28. To quantify the GSL content, the glycan component of
the GSLs was released by enzymatic digestion with GSL-speciﬁc
endo-glycoceramidase I and II (EGCase I and II) derived from Rho-
dococcus species29 (EGCase II; Takara Bio Inc.). The EGCase-digested
solutions were subjected to glycoblotting using a protocol reported
previously28. Samples were subjected to matrix-assisted laser
desorption ionization-time-of-ﬂight/time-of-ﬂight (MALDI-TOF/
TOF) mass spectrometry (MS) analysis on an Ultraﬂex II TOF/TOF
mass spectrometer (BrukerDaltonics, Billerica,MA) equippedwith a
reﬂector, and controlled by the FlexControl 3.0 software package
(Bruker Daltonics). Peaks were detected as proton-adducted ions.
Masseswere annotated using the FlexAnalysis 3.0 software package
with reference to the GlycoSuiteDB (http://glycosuitedb.expasy.org/
glycosuite/glycodb) and SphinGOMAP (http://www.sphingomap.
org/) databases for the structural identiﬁcation of glycans.
Statistical analysis
Data are expressed as means and 95% conﬁdence intervals
(95% CI). All data were checked for homogeneity of variance using
Bartlett’s test. Continuous variables were evaluated using two-
way factorial analysis of variance (ANOVA) followed by Tukeye
Kramer multiple comparison tests. When variances were signiﬁ-
cantly different, non-parametric Wilcoxon tests with Bonferroni
correction were used. Comparison of data from two groups of
samples was performed using Student’s t test. Mankin scores
were compared using non-parametric Wilcoxon test. P values of
less than 0.05 were considered signiﬁcant. Data analysis was
carried out using statistical software JMP Pro 10.0 (SAS Institute,
Cary, NC).
Results
Depletion of gangliosides in mice enhances the development of OA
with aging
Mice were followed to 15 months of age to assess the sponta-
neous development of OA with aging. At 4 months of age, there
were no signiﬁcant OA changes in the knee joints when comparing
WT and GM3S/ mice [Fig. 2(A)]. Mankin scores showed no sig-
niﬁcant difference between the mouse genotypes (WT: 0.67 (95%
CI: 0.12e1.21), GM3S/: 0.83 (95% CI: 0.04e1.62) [P¼ 0.78]; n ¼ 6).
At 15 months of age, slight OA changes were detected in the knee
joints of theWTmice, wheremild, superﬁcial cartilage erosion, and
a slight reduction in Safranin O staining were observed [Fig. 2(A)].
On the other hand, the joints of 15-month-old GM3S/ mice
exhibited greater OA changes, including joint deterioration,
compared to those of WT mice [Fig. 2(A)]. These histologic ﬁndings
were quantitatively conﬁrmed by Mankin scores (WT: 4.17 (95% CI:
3.13e5.20), GM3S/: 6.17 (95% CI: 4.77e7.56) [P¼ 0.023]; n¼ 6). To
conﬁrm the hypocellularity in more deteriorated OA cartilage,
Fig. 2. Histologic features of WT and GM3S/ mice with OA -inducing procedures. A, Histologic ﬁndings of age-associated OA in WT and GM3S/ mice. HE staining and Safranin O
(Saf-O) staining are shown for each genotype at 4 months and at 15 months of age. Bars ¼ 50 mm. B, Histologic ﬁndings of instability-induced OA in WT and GM3S/ mice. HE
staining and Saf-O staining are shown for each genotype at 8 weeks after knee operation. Bars ¼ 50 mm. C, HE staining of whole knee joints from instability-induced model mice.
Bars ¼ 500 mm.
F. Sasazawa et al. / Osteoarthritis and Cartilage 22 (2014) 313e322316chondrocyte numbers in the tibial side of the knee were manually
counted; a signiﬁcant decrease was observed in GM3S/ mice
compared to WT mice (WT: 551.83 (95% CI: 490.47e613.20),
GM3S/: 472.0 (95% CI: 424.55e519.45) [P ¼ 0.026]; n ¼ 6).Depletion of gangliosides in mice enhances the development of
instability-induced OA
We analyzed the development of instability-induced OA
changes in WT and GM3S/ mice. In the sham-operated knees, no
signiﬁcant OA changes were observed in either mouse genotype. At
8 weeks after instability-inducing surgery, the joints of WT mice
showed moderate OA changes with cartilage erosion and reduction
in Safranin O staining [Fig. 2(B)]. The depletion of gangliosides
resulted in more severe OA changes. In the joints of GM3S/ mice
at 8 weeks after surgery, the non-calciﬁed zone was almost
completely lost, and the cartilage erosion extended into the calci-
ﬁed zone beneath the tidemark. Quantitative assessment using the
Mankin scale supported these histologic ﬁndings (WT: 7.50 (95% CI:
6.62e8.38) GM3S/: 9.50 (95% CI: 8.21e10.79), [P ¼ 0.013]; n ¼ 6).
Other OA ﬁndings, such as inﬁltration of inﬂammatory cells,
osteophyte formation, or subchondral bone accrual, were notobserved in their whole knee joints [Fig. 2(C), Supplementary
Fig. 1].Depletion of gangliosides in mice enhances IL-1a-induced cartilage
degradation
Histologic examination of the explants without IL-1a stimula-
tion revealed no signiﬁcant difference in Safranin O or TUNEL
staining between the mouse genotypes [Fig. 3(A)]. Under IL-1a
stimulation, Safranin O staining for proteoglycans was reduced in
GM3S/ mouse cartilage compared to WT mouse cartilage
[Fig. 3(A)]. TUNEL staining was enhanced in GM3S/ mouse
cartilage compared to WT mouse cartilage [Fig. 3(A)]. To measure
the occurrence of apoptosis, the TUNEL-positive cells were counted
to permit calculation of the TUNEL-positive cell ratio [Fig. 3(B)]. The
ratio was signiﬁcantly elevated in chondrocytes from GM3S/mice
compared to those from WT mice (WT: 17.42% (95% CI: 14.68e
20.16%), GM3S/: 31.34% (95% CI: 27.19e35.49%) [P < 0.0001];
n ¼ 6). Immunostaining for MMP-13 also was signiﬁcantly
enhanced in GM3S/ mouse cartilage compared to WT mouse
cartilage [Fig. 3(A)]. MMP-13-positive cell ratio in chondrocytes
from GM3S/ mice was also signiﬁcantly elevated compared to
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Fig. 3. Cartilage degradation induced by interleukin-1a (IL-1a) stimulation. A, Histologic ﬁndings in cartilage explants from WT and GM3S/ mice, cultured with IL-1a and
subjected to Safranin O (Saf-O) staining, terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) staining, and MMP-13 immunostaining. Bars ¼ 10 mm. B, TUNEL-
positive cell ratio in cultured cartilage explants fromWT and GM3S/ mice (n ¼ 6). C, MMP-13-positive cell ratio in cultured cartilage explants fromWT and GM3S/ mice (n ¼ 6).
D, Proteoglycan release in cultured cartilage explants from WT and GM3S/ mice (n ¼ 4 samples (eight mice) per group). E, Quantiﬁcation of MMP-13 release in mouse femoral
head culture supernatant, as determined by ELISA (GM3S/: n ¼ 5 samples (10 mice) and WT: n ¼ 8 samples (16 mice) per group). BeE, Values are the means and 95% CI.
**: P < 0.01 vs WT mice.
F. Sasazawa et al. / Osteoarthritis and Cartilage 22 (2014) 313e322 317those fromWTmice (WT: 51.79% (95% CI: 48.61e54.96%), GM3S/:
40.04% (95% CI: 35.20e44.88%) [P ¼ 0.0042]; n ¼ 6) [Fig. 3(C)].
Under in vitro conditions, IL-1a stimulation caused a signiﬁcant
elevation in the percentage release of proteoglycans in GM3S/
mouse cartilage compared to that in WT mouse cartilage (WT:
48.33% (95% CI: 45.20e51.47%), GM3S/: 57.45% (95% CI: 49.37e
65.53%) [P ¼ 0.0071]) [Fig. 3(D)]. In this analysis, we made four
femoral heads (two mice) as one sample. We utilized four samples
(eight mice) per group.We found signiﬁcant elevations in MMP-13 protein concentra-
tion in the IL-1a-containing medium used to culture cartilage ex-
plants from GM3S/ mice compared that from WT mice (WT:
344.04 pg/ml (95% CI: 275.90e412.18 pg/ml), GM3S/: 580.11 pg/
ml (95% CI: 499.56e660.65 pg/ml) [P < 0.0001]) [Fig. 3(E)]. In
addition, elevations in NO concentrationwere found in themedium
used to culture cartilage explants from GM3S/ mice compared to
that from WT mice, but they were not statistically signiﬁcant (WT:
10.43 mM (95% CI: 9.26e11.60 mM), GM3S/: 12.88 mM (95% CI:
F. Sasazawa et al. / Osteoarthritis and Cartilage 22 (2014) 313e32231811.66e14.11 mM) [P ¼ 0.0942]) [Supplementary Fig. 2]. In these
analyses, we made four femoral heads (two mice) as one sample.
We utilized ﬁve samples (10 mice) of GM3S/ mice and eight
samples (16 mice) of WT mice per group.Depletion of gangliosides upregulates expression of genes encoding
matrix-degrading enzymes in chondrocytes cultured with IL-1a
To conﬁrm the in vivo ﬁndings under in vitro conditions, mRNA
expression levels of genes encoding two major matrix-degrading
enzymes, MMP-13 and ADAMTS-5, were measured in IL-1a-
cultured chondrocytes from mice of both genotypes (n ¼ 3).
Cultured chondrocytes were collected after 0, 6, 12, 24, and 48 h of
stimulationwith IL-1a, and transcript levels were plotted over time
[Fig. 4(A) and (B)]. Similar trends were observed for the transcripts
of both genes: mRNA levels gradually increased, peaking at 12 h
before subsequently falling. At 12 h, mRNA levels in chondrocytes
from GM3S/ mice were signiﬁcantly elevated compared to those
from WT mice (MMP-13: WT: 0.91 (95% CI: 0.58e1.24), GM3S/:
1.57 (95% CI: 1.41e1.73) [P < 0.0001]; A Disintegrin and Metal-
loproteinase with ThromboSpondinmotifs (ADAMTS)-5:WT: 0.028
(95% CI: 0.021e0.035), GM3S/: 0.051 (95% CI: 0.044e0.058)
[P < 0.0001]; n ¼ 3). The Ct values of GAPDH were stable under
these experimental conditions.Fig. 4. Relative gene expression for genes encoding MMP-13 (A) and ADAMTS-5 (B) at
the indicated time points after stimulation with IL-1a. Quantitative real-time reverse
transcriptionepolymerase reaction analysis was performed in chondrocytes from
WT and GM3S/ mice cultured with or without IL-1a (shown in the graph as (þ) and
(), respectively). The mRNA expression levels of each target gene are normalized to
the cycle threshold of the glyceraldehyde 3-phosphate dehydrogenase (GAPDH)-
encoding transcript. Values are the means and 95% CI (n ¼ 3). **: P < 0.01 vs WT mice.Overexpression of GM3S suppresses the levels of MMP-13- and
ADAMTS-5-encoding transcripts in chondrocytes cultured with IL-
1a
As a control, we demonstrated that transfection of chondrocytes
with a GM3S plasmid vector yielded an approximately 70-fold in-
crease in the quantity of GM3SmRNA compared to cells transfected
with a mock vector (mock vector: 0.015 (95% CI: 0.0017e0.023),
GM3S vector: 1.06 (95% CI: 0.16e1.96) [P¼ 0.038]; n¼ 3) [Fig. 5(A)].
The combination of GM3S transfection and 12 h of stimulationwith
IL-1a yielded signiﬁcant (compared to control samples) decreases
in the levels of MMP-13 (mock vector: 5.40 (95% CI: 4.37e6.43),
GM3S vector: 3.02 (95% CI: 2.02e4.02) [P¼ 0.002]; n¼ 3) [Fig. 5(B)]
and ADAMTS-5-encoding mRNA (mock vector: 0.051 (95% CI:
0.036e0.067), GM3S vector: 0.026 (95% CI: 0.022e0.031)
[P ¼ 0.014]; n ¼ 3) [Fig. 5(C)]. Notably, in the absence of IL-1a
stimulation, chondrocytes with enhanced GM3S expression
exhibited no apparent changes in the levels of MMP-13 or
ADAMTS-5-encoding mRNAs (data not shown). The Ct values of
GAPDH were stable under these experimental conditions.
Gangliosides are the dominant species of GSLs
Among all the GSL species, gangliosides (ganglio-series), globo-
series, and (neo)lacto-series were detected at measurable quanti-
ties; others were detected only at trace amounts. The amount of
gangliosides was signiﬁcantly higher than that of globo-series and
(neo)lacto-series at almost all time points [Fig. 6, Table I]. This
analysis also showed that the amount of gangliosides gradually
increased in a time-dependent manner until 48 h. The amounts at
24 and 48 h were signiﬁcantly higher than the original amount
(0 h): ganglioside concentrations (expressed as pmol per 1  106
cells) were 10.90 (95% CI: 0.063e21.74) at 0 h and 34.66 (95% CI:
20.81e48.51) at 48 h [P < 0.0001] (n ¼ 3).
Discussion
GSLs have been shown to play suppressive roles in a mouse
model of arthritis6. Among GSLs, gangliosides, including GM3 and
its derivatives, are known to be related to arthritis diseases10e12.
Therefore, we hypothesized that gangliosides have a critical role in
OA pathogenesis. To test our hypothesis, three different OA models,
age-associated, instability-induced, and IL-1a-induced models,
were assessed in GM3S deletion mice. The current study showed
that the depletion of gangliosides accelerated OA development in
all three models. Interestingly, younger GM3S/ mice exhibited a
phenotype similar to that of WT mice; with age, signs of age-
associated arthritis were more severe in the mutant mice
compared to the WT animals. These observations suggest that
ganglioside deﬁciency has age-associated effects on chondrocyte
activities such asmaintaining homeostasis ormatrix fragility. These
ﬁndings are strongly reminiscent of the phenotype of Ugcg/mice,
which harbor a chondrocyte-speciﬁc depletion of GSLs6.
Inﬂammation is one of the important factors in OA pathogen-
esis30,31. Among GSLs, gangliosides are known to be associated with
inﬂammatory reaction. However, the relationship between gan-
gliosides and inﬂammation is still controversial32e36. We have
previously shown that accelerated immunoreactions were
observed in rheumatoid arthritis model with GM3S/ mice12,
suggesting that the acceleration of inﬂammatory reactions was the
most suspicious reason for the enhancement of OA in GM3S/
mice. We intensively examined the histologic ﬁndings of
instability-induced model mice to assess the inﬂammation to
discover if the invasion of the instability-inducing procedurewould
have triggered inﬂammatory reactions. However, both genotypes of
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Fig. 5. Association of the overexpression of the gene encoding GM3 synthase (GM3S) with down-regulated expression of the genes encoding MMP-13 and ADAMTS-5 in response to
stimulation with interleukin-1a (IL-1a) in chondrocytes from WT mice. A, GM3S mRNA expression in the chondrocytes was up-regulated at 48 h after transfection. B, C, Chon-
drocytes overexpressing GM3S and stimulated with IL-1a had signiﬁcantly suppressed levels of MMP-13 e (B) and ADAMTS-5 e (C) encoding mRNA, as compared with those in
chondrocytes without overexpression and without IL-1a stimulation. The mRNA expression values of each target gene are normalized to the cycle threshold of the GAPDH-encoding
transcript. Values are the means and 95% CI (n ¼ 3). *: P < 0.05, and **: P < 0.01.
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We consider two possible reasons for this result. First, the induced
inﬂammation was merely so mild that we couldn’t detect the dif-
ference. Second, the instability-inducing procedure didn’t stimulate
Th-17 cells which produce IL-17, because the accelerated immu-
noreactions which we observed in our previous study were trig-
gered by IL-17 instead of IL-1. It is generally accepted that the
elevation of IL-17 level in synovial ﬂuid is observed not in OA pa-
tients but in rheumatoid arthritis patients37. In addition to
inﬂammation, we could also observe only little osteophyte forma-
tion and subchondral bone accrual. Based on these ﬁndings, we
supposed that the OA pathogenesis in these models might exist in
the articular cartilage itself.
The pathophysiology of OA consists primarily of the enhance-
ment of chondrocyte apoptosis and the increased production of
matrix-degrading enzymes38,39. Some previous studies have shown
that gangliosides in neural, cardiac, and hepatic cells have tissue-
protective effects against oxidative stress or apoptosis40e44. Our
results demonstrated that deletion of GM3S enhanced the IL-1a-
stimulated induction of chondrocyte apoptosis and elevated
expression of genes encoding matrix-degrading enzymes. There-
fore, we hypothesized that gangliosides would play suppressive
roles in OA pathogenesis. To conﬁrm this hypothesis, transient
GM3S transfectionwas applied to chondrocytes harvested fromWT
mice and exposed to IL-1a. The overexpression of GM3SFig. 6. Quantiﬁcation by MS of GSLs in cultured mouse chondrocyte pellets. Time-depende
points after stimulation with IL-1a. The levels of gangliosides were signiﬁcantly higher than
the means and 95% CI (n ¼ 3). *: P < 0.05, and **: P < 0.01.signiﬁcantly suppressed the accumulation ofMMP-13 and ADAMTS-
5 transcripts after IL-1a stimulation. Thus, we propose that, in
chondrocytes, gangliosides exert chondroprotective effects by
suppressing the expression of MMP-13- and ADAMTS-5-encoding
genes.
GSLs are a complex of diverse molecules; each series of GSLs is
known to be related to several biological phenomena9,45e47.
Notably, gangliosides, which are synthesized by GM3S, have a
relationship with OA pathogenesis, as demonstrated in previous
analyses using human cartilage10,11. As a ﬁrst step in testing our
hypothesis, we examined mice depleted for ganglioside GM3 and
its derivatives as a result of mutation of the GM3S gene. The
depletion of GM3 and its derivatives yielded clinical signs of OA
with severity equivalent to that seen in mice depleted for a whole
range of GSLs6. This result suggests that GM3 and its derivatives are
the (functionally) dominant GSL species in chondrocytes. To
address the relative abundance of different species in this cell type,
we proﬁled all GSLs by MS after IL-1a stimulation. This analysis
revealed that ganglio-series (a-, and b-series) gangliosides are the
most abundant series of GSLs [Fig. 6]. These results indicate that,
among various series of GSLs, gangliosides play a dominant role in
OA pathogenesis.
The ultimate purpose of OA research is to clarify the patho-
genesis of OA and to develop treatments for this illness, such as
disease-modifying osteoarthritis drugs (DMOADs)48. To facilitatent changes of GSL amounts in cultured chondrocytes are shown at the indicated time
those of the globo-series and (neo)lacto-series at almost all the time points. Values are
Table I
Values of quantiﬁcation of GSLs by MS. Values are the means and 95% CI (pmol/1 106 cells). *P < 0.05 and **P < 0.01 vs the amount of gangliosides at each time point after
stimulation with IL-1a
Stimulation
time (h)
0 6 12 24 48
Gangliosides 10.90 (0.063e21.74) 19.56 (10.5e28.63) 17.98 (2.58 to 38.55) 28.08 (6.58e49.57) 34.66 (20.81e48.51)
Globo-series 4.20 (1.67e6.73)
(P ¼ 0.76)
7.11* (0.79e7.74)
(P ¼ 0.038)
6.27 (2.19e10.36)
(P ¼ 0.065)
8.50** (3.79 - 13.20)
(P ¼ 0.0001)
8.85** (1.54e16.15)
(P < 0.0001)
(Neo)Lacto-series 3.61 (1.6 to 8.83)
(P ¼ 0.65)
4.26** (0.79e7.74)
(P ¼ 0.0043)
3.49** (0.28 to 7.25)
(P ¼ 0.0081)
5.56** (0.3e10.83)
(P < 0.0001)
4.78** (2.45e7.11)
(P < 0.0001)
Fig. 7. Scheme of the effects of inhibition of GSL synthetic pathway. Gray shaded frame represents molecules absent in mice. A, WT mice. B, Ugcg/ mice exhibit embryonic
lethality6e8. C, GM3S/ mice show OA development without apparent growth impairment.
F. Sasazawa et al. / Osteoarthritis and Cartilage 22 (2014) 313e322320clinical application, more efﬁcacious drugs with reduced side-
effects will be needed. Although cartilage-speciﬁc Ugcg/ mice
showed an enhancement of OA, uridine diphosphate (UDP)-glucose
ceramide glucosyltransferase is not an ideal therapeutic target
because the phenotype of Ugcg null-KO mice is known to be em-
bryonic lethal6e8 [Fig. 7(A) and (B)]. This fact indicates that Ugcg-
targeted OA therapy might cause serious systemic effects. Our re-
sults revealed that GM3S null-KO mice enhanced OA development
without growth deﬁciency13 [Fig. 7(C)], suggesting that GM3S and
its enzymatic products are candidate targets for therapies that may
exert less inﬂuence on systemic conditions than the Ugcg gene
product.
There are several limitations to this study. First, we note the
possible effects on OA pathogenesis of compensatory increases in
the levels of o-series gangliosides. A recent study proﬁling GSLs in
GM3S/ mice revealed elevated production of o-series ganglio-
sides in GM3S/ mice [Fig. 1]49. Further elucidation of the dy-
namics of GSLs in GM3S/ mice will contribute to better
understanding of GSL-dependent processes. Second, the precise
mechanism of OA development in ganglioside-depleted animals is
not fully understood. Although our data suggests that gangliosides
may exert chondro-protective effects by suppressing chondrocyte
apoptosis and the expression of matrix degrading enzymes, the
mechanisms by which gangliosides regulate these processes are
still unknown. Despite these limitations, the current study supports
a role for GSLs in OA pathogenesis, emphasizing the importance of
the GSL synthetic pathway distinct from the steps extending from
GlcCer synthase [Fig. 1]6 to GM3 synthase. Further research will be
needed to clarify the possible involvement in OA pathogenesis of
other (downstream) components of the GM3 synthetic pathway.In conclusion, the depletion of gangliosides enhanced OA
development, elevating MMP-13 and ADAMTS-5 expression and
accelerating chondrocyte apoptosis. Moreover, the over-
expression of GM3S in vitro suppressed MMP-13 and ADAMTS-5
expression. These results suggest that gangliosides play a sup-
pressive role in OA development and may provide a target for the
design of novel anti-OA therapeutics. Further work will be
required to identify the speciﬁc ganglioside(s) responsible for OA
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